Log In
Print
BCIQ
Print
Print this Print this
 

DM-1992

  Manage Alerts
Collapse Summary General Information
Company Depomed Inc.
DescriptionGastric-retentive extended-release formulation of levodopa/carbidopa
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today